Search results
Amgen's (AMGN) Blincyto Gets FDA Nod for Consolidation Treatment
Zacks via Yahoo Finance· 2 days agoAmgen's (AMGN) Blincyto is now approved for the treatment of adult and pediatric patients one month...
Secret Pentagon Anti-Vax Campaign; FDA's Tylenol Warning; E. Coli at the Olympics
MedPage Today· 2 days agoThe U.S. military waged a secret campaign in the Philippines during the pandemic to cast doubt on...
What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday? - Nurix Therapeutics...
Benzinga· 2 days agoImbruvica (Ibrutinib), and AstraZeneca Plc’s AZN Calquence (Acalabrutinib). NX-5948 is being...
How to Safely Discontinue Multiple Myeloma Maintenance Care
Medscape· 5 days agoNew research suggested that the key to safely discontinuing multiple myeloma maintenance therapy is...
Nurix Therapeutics (NASDAQ:NRIX) Shares Gap Up Following Analyst Upgrade
ETF DAILY NEWS· 1 day agoNurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) gapped up before the market opened on Monday after JPMorgan Chase & Co. raised their price target on the stock from $30.00 to $31.00.
Evolution May Be Purposeful And It’s Freaking Scientists Out
Forbes· 5 days ago“Where are all the genetic cures?” asks Denis Noble, a frustrated biophysicist, Royal Society fellow...
Epstein-Barr virus: how does a common infection trick the immune system into attacking the brain in...
The Conversation· 1 day agoAlmost 3 million people worldwide have multiple sclerosis (MS) – an autoimmune disease caused by the immune system mistakenly attacking the brain and central nervous system. While treatments ...
Kyverna's CAR-T relapse in lupus dents autoimmune hopes amid biotech gold rush
FierceBiotech· 2 days agoThe “remarkable” success of chimeric antigen receptor T-cell therapy (CAR-T) in lupus has led to a...
Three-Drug Regimen Shows OS Benefit in Third-Line DLBCL
MedPage Today· 2 days agoLoretta Nastoupil, MD, leads a discussion on the ECHELON-3 trial results
Boosting CAR-T cell therapies from under the skin
Medical Xpress· 7 days agoCAR-T cells are created from a patient's own immune T cells by introducing so-called "chimeric antigen receptors" (CARs) to their molecular repertoires that enable them to seek out and kill ...